{
    "Trade/Device Name(s)": [
        "i-STAT CK-MB test",
        "i-STAT Cardiac Troponin I test",
        "i-STAT CK-MB Test",
        "i-STAT cTnl Test"
    ],
    "Submitter Information": "i-STAT Corporation",
    "510(k) Number": "K051433",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYT",
        "MMI"
    ],
    "Summary Letter Date": "December 15, 2005",
    "Summary Letter Received Date": "November 29, 2005",
    "Submission Date": "November 26, 2005",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatine Kinase MB (CK-MB)",
        "Cardiac Troponin I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "i-STAT 1 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Two-site ELISA",
        "Immunoassay",
        "Electrochemical detection",
        "Enzyme-linked antibody assay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for i-STAT CK-MB and Cardiac Troponin I tests using quantitative immunoassay on i-STAT 1 Analyzer for myocardial infarction diagnosis and risk stratification.",
    "Indications for Use Summary": "For quantitative measurement of CK-MB and cardiac troponin I in whole blood or plasma as an aid in diagnosis and treatment of myocardial infarction and risk stratification of acute coronary syndromes.",
    "fda_folder": "Clinical Chemistry"
}